Hill-Rom Holdings Inc (HRC) to Issue Quarterly Dividend of $0.18
Hill-Rom Holdings Inc (NYSE:HRC) declared a quarterly dividend on Wednesday, July 19th, Zacks reports. Investors of record on Friday, September 15th will be given a dividend of 0.18 per share by the medical technology company on Friday, September 29th. This represents a $0.72 annualized dividend and a yield of 0.86%. The ex-dividend date is Thursday, September 14th.
Hill-Rom Holdings has increased its dividend payment by an average of 8.2% per year over the last three years and has raised its dividend annually for the last 6 consecutive years. Hill-Rom Holdings has a payout ratio of 18.7% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Hill-Rom Holdings to earn $4.36 per share next year, which means the company should continue to be able to cover its $0.72 annual dividend with an expected future payout ratio of 16.5%.
Shares of Hill-Rom Holdings (NYSE:HRC) traded up 0.40% during mid-day trading on Thursday, hitting $83.80. 23,050 shares of the company’s stock traded hands. The company has a market cap of $5.51 billion, a PE ratio of 36.20 and a beta of 1.23. The firm has a 50-day moving average of $80.22 and a 200 day moving average of $70.72. Hill-Rom Holdings has a 52 week low of $50.50 and a 52 week high of $84.65.
Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings results on Friday, April 28th. The medical technology company reported $0.88 EPS for the quarter, topping analysts’ consensus estimates of $0.79 by $0.09. The company had revenue of $678.90 million for the quarter, compared to analyst estimates of $654.27 million. Hill-Rom Holdings had a net margin of 5.80% and a return on equity of 19.77%. Hill-Rom Holdings’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.71 earnings per share. Equities research analysts predict that Hill-Rom Holdings will post $3.86 EPS for the current year.
A number of equities analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, July 11th. Barclays PLC lifted their target price on shares of Hill-Rom Holdings from $80.00 to $86.00 and gave the stock an “overweight” rating in a research note on Friday, June 9th. Cantor Fitzgerald assumed coverage on shares of Hill-Rom Holdings in a research note on Thursday, June 29th. They set a “neutral” rating and a $86.00 target price for the company. Needham & Company LLC assumed coverage on shares of Hill-Rom Holdings in a research note on Thursday, June 29th. They set a “buy” rating and a $95.00 target price for the company. Finally, Morgan Stanley lifted their target price on shares of Hill-Rom Holdings from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Friday, June 30th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. Hill-Rom Holdings presently has a consensus rating of “Buy” and a consensus target price of $88.50.
In other news, SVP Andreas G. Frank sold 10,660 shares of the business’s stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $78.62, for a total transaction of $838,089.20. Following the completion of the sale, the senior vice president now directly owns 28,988 shares of the company’s stock, valued at $2,279,036.56. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Paul Sherwood Johnson sold 2,078 shares of the business’s stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $72.30, for a total transaction of $150,239.40. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.